Andere talen Verve Therapeutics, Inc.

Aandelen

VERV

US92539P1012

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,66 ^USD	-1,19%		-17,47%	-52,22%

03/04	VERVE THERAPEUTICS, INC. : Stifel Nicolaus handhaaft koopadvies	ZM
02/04	Sectorupdate: Gezondheidszorgaandelen dalen aan het eind van de middag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Slide Late Afternoon	02/04
Top Midday Decliners	02/04
Looming Factory Orders, Job Openings Data Prompt Lower Premarket Action for US Equity Futures	02/04
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday	02/04
Sector Update: Health Care	02/04
Verve Therapeutics Pauses Heart-1 Trial After Serious Adverse Events; Shares Fall Pre-Bell	02/04
Top Premarket Decliners	02/04
Verve Therapeutics Announces Updates on its PCSK9 Program	02/04
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels	02/04
Verve Therapeutics, Inc. Announces Updates on its PCSK9 Program	02/04
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	28/03
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	01/03
Verve Therapeutics Q4 Net Loss Widens, Collaboration Revenue Rises; Beats Estimates; Shares Rise	27/02
Verve Therapeutics: Q4 Earnings Snapshot	27/02
Verve Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results	27/02
Verve Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	01/02
Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	01/02
Certain Restricted Stock Units of Verve Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Verve Therapeutics, Inc.

Aandelen

VERV

US92539P1012

Andere talen

Filters